Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in <i>Escherichia coli</i> Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20
Urinary tract infections (UTIs) are among the most common bacterial infections in humans. <i>Escherichia coli</i> is by far the leading cause of community-acquired UTIs. Pivmecillinam, the oral prodrug of the penicillin derivative mecillinam (amdinocillin), was re-introduced in Germany i...
Saved in:
Main Authors: | Michael Kresken (Author), Yvonne Pfeifer (Author), Florian Wagenlehner (Author), Guido Werner (Author), Esther Wohlfarth (Author), on behalf of Study Group 'Antimicrobial Resistance' of the Paul Ehrlich Society for Infection Therapy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17
by: Esther Wohlfarth, et al.
Published: (2023) -
Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Karoline Knudsen List, et al.
Published: (2022) -
Genome-Based Analyses of Fitness Effects and Compensatory Changes Associated with Acquisition of <i>bla</i><sub>CMY</sub>-, <i>bla</i><sub>CTX-M</sub>-, and <i>bla</i><sub>OXA-48/VIM-1</sub>-Containing Plasmids in <i>Escherichia coli</i>
by: Michael Pietsch, et al.
Published: (2021) -
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023) -
Determination of a Tentative Epidemiological Cut-Off Value (ECOFF) for Dalbavancin and <i>Enterococcus faecium</i>
by: Robert E. Weber, et al.
Published: (2021)